Methods of use of FGF homologs

Details Methods of use of FGF homologs Methods of use of FGF homologs

2006-11-14

2006-11-14

Saoud, Christine J. (Department: 1647)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S825000, C530S350000, C530S399000

Reexamination Certificate

active

07135459

ABSTRACT:
The present invention relates to methods of using zFGF5 compositions to proliferate chondrocytes and their progenitors, and to induce deposition of cartilage. zFGF5 compositions are disclosed for treating disorders associated with chondrocytes, such as cartilage injuries and defects. In addition, methods for treating neurological disorders, such as stroke, are disclosed, and methods for using zFGF5 compositions to stimulate growth of cells associated with neurological injury and disease are disclosed.

REFERENCES:
patent: 5439818 (1995-08-01), Fiddes et al.
patent: 5514566 (1996-05-01), Fiddes et al.
patent: 5604293 (1997-02-01), Fiddes et al.
patent: 6013477 (2000-01-01), Greene et al.
INC313182, LIFESEQ™ Clone Information Results, Incyte Pharmaceuticals Inc., 1995.
Goldfarb,Cell Growth and Differentiation1:439-445, 1990.
Long et al.,Cell Regulation2:1081-1095, 1991.
Crossley et al.,Cell84:127-136, 1996.
Mickle et al.,Med Clin North Am84(3):597-607, 2000.
Voet et al., “Biochemistry,” pp. 126-128 and 228-234, John Wiley & Sons, 1990.
Yan et al.,Science290:523-527, 2000.

Affiliated with

Also associated with

Rating

Methods of use of FGF homologs does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of use of FGF homologs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of use of FGF homologs will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3652820